The app will be made available to patients and doctors with added features, and to researchers and pharmaceutical companies to study diseases and predict drug sales. Initially, it will target users in major cities and be available to patients on smartphones and in medium-sized hospitals. The app will be free for patients at first to promote usage, and priced competitively for other audiences based on features. It will be promoted through word of mouth from patients and endorsement by doctors.